PI3K/AKT抑制劑化合物與HER3/EGFR抑制劑化合物的組合及使用方法
- 专利权人:
- THE GENERAL HOSPITAL CORPORATION
- 发明人:
- BASELGA, JOSE,SCALTRITI, MAURIZIO
- 申请号：
- HK15112070.1
- 公开号：
- HK1211218A
- 申请日:
- 2015.12.08
- 申请国别(地区):
- HK
- 年份:
- 2016
- 代理人:
- 摘要：
- The invention provides combinations comprising GDC-0068 or GDC-0941, or a pharmaceutically acceptable salt thereof and ME-HD7945A. The combinations are particularly useful for treating hyperproliferative disorders, such as cancer (e.g., triple negative breast cancer).
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- COMBINAISONS D'UN COMPOSE INHIBITEUR DE PI3K/AKT AVEC UN COMPOSE INHIBITEUR DE HER3/EGFR ET LEUR UTILISATION DANS LE TRAITEMENT D'UN TROUBLE HYPERPROLIFERATIF
- КОМБИНАЦИЯ ИНГИБИТОРА MEK И ИНГИБИТОРА ERK ДЛЯ ПРИМЕНЕНИЯ В ЛЕЧЕНИИ ГИПЕРПРОЛИФЕРАТИВНЫХ ЗАБОЛЕВАНИЙ
- КОМБИНАЦИИ СОЕДИНЕНИЯ ИНГИБИТОРА МЕК С СОЕДИНЕНИЕМ ИНГИБИТОРОМ HER3/EGFR И СПОСОБЫ ПРИМЕНЕНИЯ
- Combinations of a PI3K/AKT inhibitor compound with an HER3/EGFR inhibitor compound and use thereof in the treatment of a hyperproliferative disorder
- COMBINATIONS OF A PI3K/AKT INHIBITOR COMPOUND WITH AN HER3/EGFR INHIBITOR COMPOUND AND USE THEREOF IN THE TREATMENT OF A HYPERPROLIFERATIVE DISORDER
